Cell and gene therapy-related research and development in the US continue to grow at a fast rate, with the FDA signaling its interest in moving these products to clinical development. While the promise of breakthrough treatments is tantalizing, researchers and pharma companies in the US are still in the early stages of getting these new therapies reviewed, approved and available to patients who need them.

Join our panel for a discussion of the current state of gene therapy commercialization with scientist-entrepreneurs on the front lines of research and discovery.

JOIN THE WEBINAR ON ZOOM, APRIL 8